OGN and breast cancer: In the selected key specific DEGs for Basal-subtype breast cancer, the altered expression of SOX11, PLK1, BUB1, OGN, COL4A6, AGTR1, and ADRB2 were significantly correlated with the prognostic survival of the patients.